In order to follow the original classification of the cohort used in this study [4,5], the breast cancer specimens have been classified as: luminal-A, luminal-B (HER2-negative), luminal-B (HER2-positive), HER2-enriched and triple-negative breast cancers. This evidence concerns the gene ERBB2 and breast cancer.